CNTN.US Canton Strategic Holdings, Inc.

Healthcare Biotechnology USA Stocks
1.71 USD
Close of Nov 14, 2026
1.66 5.83
Market cap
USD 136M
P/E
-
P/B
0.32x
ROE
-29.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CNTN.US undervalued?

Graham number

The Graham number of Canton Strategic Holdings, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Canton Strategic Holdings, Inc. fundamental analysis

No fundamental analysis for Canton Strategic Holdings, Inc. yet.

Canton Strategic Holdings, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Canton Strategic Holdings, Inc.

Canton Strategic Holdings, Inc. focuses on advancing institutional blockchain adoption and digitizing financial markets in the United States. The company operates as a validator and super validator on the Canton Network, which provides validation and liveness services to the network. It also provides locking-as-a-service (LaaS) to Canton Network super validators and featured applications, which locks its own Canton Coin (CC) on a customer's behalf while retaining legal and b…

Full company profile